Posted On: 24 AUG 2021 7, Delhi



*Cover your face with masks to prevent transmission of droplets carrying coronavirus
*Exercise social distancing
*Wash your hands frequently
*Sanitize your hands

Over 59 Cr. vaccine doses have been administered so far under Nationwide Vaccination Drive25,467 new cases in the last 24 hoursActive cases account for less than 1% of total cases, currently at 0.98%; lowest since March 2020India’s Active caseload stands at 3,19,551; lowest in 156 daysRecovery Rate increases to 97.68%; Highest since March 202039,486 recoveries in the last 24 hours increases Total Recoveries to 3,17,20,112Weekly Positivity Rate (1.90%) less than 3% for last 60 daysDaily positivity rate (1.55%) less than 3% for last 29 days50.93 cr Total Tests conducted so far






COVID-19 Update

India’s Cumulative COVID-19 Vaccination Coverage exceeds 59 Cr

Recovery Rate (97.68%) at its highest since March 2020

25,467 New Cases reported in the last 24 hours

At less than 1% of total cases, Active Cases lowest since March 2020

India’s Active Caseload (3,19,551) lowest in 156 days is 0.98% of Total Cases

Daily Positivity Rate (1.55%) less than 3% for last 29 days

India’s COVID-19 vaccination coverage has surpassed the cumulative figure of 59 crores. As per provisional reports till 7 am today, over58.89 Cr (58,89,97,805) vaccine doses had been administered. This had been achieved through 65,03,493 sessions.

The break-up of the cumulative figure as per the provisional report till 8 am today include:

HCWs1st Dose1,03,53,692
2nd Dose82,32,742
FLWs1st Dose1,83,07,076
2nd Dose1,26,40,318
Age Group 18-44 years1st Dose22,03,32,468
2nd Dose2,03,29,375
Age Group 45-59 years1st Dose12,34,70,622
2nd Dose4,93,70,668
Over 60 years1st Dose8,36,87,351
2nd Dose1,03,53,692

The Union Government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country.

The recovery of 39,486 patients in the last 24 hours has increased the cumulative tally of recovered patients (since the beginning of the pandemic) to 3,17,20,112.

Consequently, India’s recovery rate stands at 97.68%, the highest since March 2020.

Sustained and collaborative efforts by the Centre and the States/UTs continue the trend of less than 50,000 Daily New Cases that is being reported for 58 consecutive days now.

25,467 new cases were reported in the last 24 hours.

High recoveries and a low number of new cases have subsided the Active Caseload to 3,19,551 which is at its lowest in 156 days. At 0.98%, Active cases presently form less than 1% of the country’s total Positive Cases. Active Caseload is at its lowest since March 2020.

The testing capacity across the country continues to be expanded. The last 24 hours saw a total of 16,47,526 tests being conducted. India has so far conducted over 50.93 Cr (50,93,91,792) cumulative tests.

While testing capacity has been enhanced across the country, Weekly Positivity Rate at 1.90% remains less than 3% for the last 60 days now. The Daily Positivity rate also stands at 1.55%. The daily Positivity rate has remained below 3% for the last 29 days and below 5% for 78 consecutive days now.


Update on COVID-19 Vaccine Availability in States/UTs 

More than 57.15 Crore vaccine doses provided to States/UTs

More than 1 Crore doses in Pipeline

As part of the nationwide vaccination drive, Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In the new phase of the universalization of the COVID19 vaccination drive, the Union Government will procure and supply (free of cost) 75% of the vaccines being produced by the vaccine manufacturers in the country to States and UTs.

 VACCINE DOSES (As on 24 August 2021)
 SUPPLIED 57,15,22,580
 PIPELINE 1,00,84,700

More than 57.15 crore (57,15,22,580) vaccine doses have been provided to States/UTs so far through Govt of India (free of cost channel) and through direct state procurement category. Further, 1,00,84,700 doses are in the pipeline.

More than 3.29 Cr (3,29,58,715) balance and unutilized COVID Vaccine doses are still available with the States/UTs to be administered.


Vice President urges medical fraternity to educate people on the safety of COVID-19 vaccine to make it a people’s movement

Calls upon people’s representatives to ensure vaccination of people in their constituencies

Vaccination is the most effective shield against COVID-19: VP

VP advises media to dispel false beliefs with accurate information

VP cautions people against complacency, says “we are still not totally out of the woods”

VP urges the private sector to supplement government’s efforts in giving boost to health infrastructure

VP launches ‘Vaccinate India Programme’

The Vice President, Shri M Venkaiah Naidu today urged the medical fraternity in general and the Indian Medical Association, in particular, to take up special awareness campaigns to educate the people about the safety and importance of getting vaccinated against COVID-19.

Inaugurating ‘Vaccinate India Programme’, an initiative of Sustainable Goals Coordination Center, Government of Karnataka in collaboration with Give India Foundation, the Vice President said, there appears to be hesitancy in some quarters to get vaccinated. It is absolutely essential to educate and create awareness among those who are still harboring doubts, he added.

Calling for turning COVID vaccination drive into a ‘Jan-Andolan’, Shri Naidu exhorted all people’s representatives to ensure that everyone is vaccinated in their constituencies. He also urged the media to educate people on the need to shed vaccine hesitancy. “False beliefs need to be dispelled by providing accurate information,” he stressed.


DBT-BIRAC supported Nation’s first mRNA-based vaccine found to be safe gets a nod from the Drugs Controller General of India DCG(I) to move into Phase II/III trial

India’s First COVID-19, mRNA vaccine developed in partnership with DBT-BIRAC under Mission COVID Suraksha

Gennova Biopharmaceuticals Ltd., the Pune-based biotechnology company, working on the nation’s first mRNA-based COVID-19 vaccine, submitted the interim clinical data of the Phase I study to the Central Drugs Standard Control Organisation (CDSCO), the Government of India’s National Regulatory Authority (NRA).

Vaccine Subject Expert Committee (SEC) reviewed the interim Phase I data and found that HGCO19 was safe, tolerable, and immunogenic in the participants of the study.

Gennova submitted the proposed Phase II and Phase III study entitled “A Prospective, Multicentre, Randomized, Active-controlled, Observer-blind, Phase II study seamlessly followed by a Phase III study to evaluate the Safety, Tolerability, and Immunogenicity of the candidate HGCO19 (COVID-19 vaccine) in healthy subjects” which was approved by the office of the DCG(I), CDSCO


Union Health Minister Shri Mansukh Mandaviya inaugurates OPD services in the new AYUSH building and night shelter at AIIMS Deoghar

“New facilities will benefit more than 3 crore population of Jharkhand”: Shri. Mansukh Mandaviya

The Union Health Minister took the occasion to point out that the Union Government under the dynamic leadership of the Prime Minister Shri. Narendra Modi has always stood by the States throughout the Pandemic. The ECRP-1 and ECRP-II (Emergency COVID19 Response Package) have played a huge role in mounting a sturdy Public Health Response to COVID. Similarly, the Pradhan Mantri Swasthya Suraksha Yojana (PMSSY) is addressing the regional imbalance in tertiary medical care and is providing quality medical education in underserved States.

Shri Mansukh Mandaviya said that centre has helped Jharkhand in every possible way in its fight against COVID-19. He invoked the concept of ‘Antyodaya’ of serving the last citizen in the society as propounded by Shri Deendayal Upadhyaya as the guiding principle of the Union Health Ministry’s efforts to implement PMSSY.


Important Tweets

Categories: National

Tagged as: ,

Leave a Reply